Table 2.
Demographic and clinical characteristics.
| Participants (n = 20) | ||
|---|---|---|
| Sex | ||
| Male | 11 (55%) | |
| Female | 9 (45%) | |
| Age, year (range) | 32.8 ± 2.9 (28–38) | |
| Anthropometric data | ||
| Height (m) | 1.7 (1.6–1.8) | |
| Weight (kg) | 61.5 (58.0–73.8) | |
| BMI (range) | 21.1 (19.7–23.4) | |
| Laboratory data | ||
| AST (U/L) | 21.5 (18.0–25.8) | |
| ALT (U/L) | 21.0 (13.3–25.0) | |
| TG (mg/dL) | 74.0 (55.8–91.8) | |
| Total cholesterol (mg/dL) | 172.0 (158.3–193.5) | |
| HDL (mg/dL) | 56.6 (44.9–64.0) | |
| LDL (mg/dL) | 103.0 (81.3–113.3) | |
| HbA1C (%) | 5.3 (5.1–5.6) |
Data are presented as n (%), the mean ± SD, or the median (Q1–Q3). BMI—body mass index, AST—aspartate transaminase, ALT—alanine transaminase, TG—triglycerides, HDL—high-density lipoprotein, LDL—low-density lipoprotein, and HbA1C—hemoglobin A1C.